2min chapter

Breakpoints cover image

#78 – New Therapies in HIV: The Long Road to Long-acting Antiretrovirals - Are We There Yet?

Breakpoints

CHAPTER

Cabotage for PrEP: The Pharmacokinetic Tail and Resistance Development

Cabotage for PrEP is much more effective than I expected it to be. It's just starting PrEP with Cabotegravir is still a rarity, at least in our clinic. So we're using way more Cabropivarine than we are Caboteg Gravir. We did the Cabotagavirinibilizumab but I think that if I had to do it again, I probably would leave the Ibalizumab all.

00:00

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode